Fundraise / allotmentNotableFiled on BSE ·
Natco Pharma approves rights issue up to ₹1,300 crore, updates scheme of arrangement
Natco Pharma Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Board approved issuing equity shares worth up to ₹1,300 crore via rights issue to eligible shareholders on September 9, 2026.
- Fund-Raising Committee formed with three members to implement the rights issue.
- Scheme of arrangement (demerger) updated to reflect changes post-rights issue; necessary filings to follow.
Why it's rated notable: not yet binding (letter of intent, proposal or subject to approvals)
Original filing
Board Meeting Outcome for Outcome Of Board Meeting
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies Ltd
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Natco Pharma Ltd
- Fundraise / allotmentNotableNatco Pharma allots 1,70,58,082 equity shares in Rights Issue at ₹750 each
- Board / shareholder meeting outcomeMajor developmentNatco Pharma Limited announces results of 43rd AGM held on 30 September 2026
- Fundraise / allotmentNotableNATCO Pharma Limited files Letter of Offer for Rights Issue closing Oct 22, 2026
- Fundraise / allotmentNotableNatco Pharma board approves rights issue of up to ₹12,79,35,61,500
- Fundraise / allotmentNotableNatco Pharma approves rights issue of up to ₹12,79,35,61,500 via 1,70,58,082 shares
Other fundraise / allotment filings this fortnight
- Regency Fincorp reports Q2 & H1 FY27 results with AUM crossing ₹600 crore
- Raymond Realty Limited receives in-principle approval for preferential issue of shares
- OnEMI Technology Solutions allots 2,64,93,882 equity shares via preferential issue
- Capital Infra Trust submits post-Institutional Placement unit holding pattern
- Capital Infra Trust raises ₹1,115 crore via QIP for acquiring six HAM road assets
- Paisalo Digital Limited approves Q2 and H1 FY2026-27 unaudited financial results
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.